Roy H. Perlis, MD, MSc

Antidepressant Nonadherence in Routine Clinical Settings Determined From Discarded Blood Samples

March 23, 2016

Ashlee M. Roberson, Victor M. Castro, Andrew Cagan, et al

Article

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders

April 16, 2015

In this naturalistic study, Brennan and colleagues evaluated the use of a commercially available genetic test—the Genecept Assay—to help guide clinician treatment decisions to improve outcomes for psychiatric patients.Â

Maurizio Fava, Roy H. Perlis, Francis X. Brennan, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder

July 15, 2013

Maurizio Fava, Andrew A. Nierenberg, Roy H. Perlis, et al

Original Research

First Experience With a Wireless System Incorporating Physiologic Assessments and Direct Confirmation of Digital Tablet Ingestions in Ambulatory Patients With Schizophrenia or Bipolar Disorder

June 15, 2013

John M. Kane, Georgios Petrides, Roy H. Perlis, et al

Original Research

Do Suicidal Thoughts or Behaviors Recur During a Second Antidepressant Treatment Trial?

September 18, 2012

Maurizio Fava, Roy H. Perlis, Rudolf Uher, et al

Original Research

Association of Common Variations in the Norepinephrine Transporter Gene With Response to Olanzapine-Fluoxetine Combination Versus Continued-Fluoxetine Treatment in Patients With Treatment-Resistant Depression: A Candidate Gene Analysis

March 6, 2012

Bonnie A. Fijal, John P. Houston, Roy H. Perlis, et al

Original Research

Risks for the Transition From Major Depressive Disorder to Bipolar Disorder in the National Epidemiologic Survey on Alcohol and Related Conditions

February 21, 2012

Roy H. Perlis, Stephen E. Gilman, Jamie M. Dupuy

Original Research

Clinical Features Associated With Poor Pharmacologic Adherence in Bipolar Disorder: Results From the STEP-BD Study

March 15, 2010

Andrew A. Nierenberg, Michael E. Thase, Gary S. Sachs, et al

Original Research

Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report

February 15, 2010

Andrew A. Nierenberg, Michael E. Thase, Gary S. Sachs, et al

Original Research

Genetic Association Study of Treatment Response With Olanzapine/Fluoxetine Combination or Lamotrigine in Bipolar I Depression

December 15, 2009

John P. Houston, Roy H. Perlis, David H. Adams, et al

Educational Activity

Efficacy of Agents in Treating Mania

April 15, 2009

Roy H. Perlis

Original Research

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD

February 10, 2009

Michael E. Thase, Terence A. Ketter, Gary S. Sachs, et al

Antidepressant Nonadherence in Routine Clinical Settings Determined From Discarded Blood Samples

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders

A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder

First Experience With a Wireless System Incorporating Physiologic Assessments and Direct Confirmation of Digital Tablet Ingestions in Ambulatory Patients With Schizophrenia or Bipolar Disorder

Do Suicidal Thoughts or Behaviors Recur During a Second Antidepressant Treatment Trial?

Association of Common Variations in the Norepinephrine Transporter Gene With Response to Olanzapine-Fluoxetine Combination Versus Continued-Fluoxetine Treatment in Patients With Treatment-Resistant Depression: A Candidate Gene Analysis

Risks for the Transition From Major Depressive Disorder to Bipolar Disorder in the National Epidemiologic Survey on Alcohol and Related Conditions

Clinical Features Associated With Poor Pharmacologic Adherence in Bipolar Disorder: Results From the STEP-BD Study

Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report

Genetic Association Study of Treatment Response With Olanzapine/Fluoxetine Combination or Lamotrigine in Bipolar I Depression

Efficacy of Agents in Treating Mania

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD

ELSEWHERE:

FOLLOW US:

Roy H. Perlis, MD, MSc

Antidepressant Nonadherence in Routine Clinical Settings Determined From Discarded Blood Samples

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders

A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder

First Experience With a Wireless System Incorporating Physiologic Assessments and Direct Confirmation of Digital Tablet Ingestions in Ambulatory Patients With Schizophrenia or Bipolar Disorder

Do Suicidal Thoughts or Behaviors Recur During a Second Antidepressant Treatment Trial?

Association of Common Variations in the Norepinephrine Transporter Gene With Response to Olanzapine-Fluoxetine Combination Versus Continued-Fluoxetine Treatment in Patients With Treatment-Resistant Depression: A Candidate Gene Analysis

Risks for the Transition From Major Depressive Disorder to Bipolar Disorder in the National Epidemiologic Survey on Alcohol and Related Conditions

Clinical Features Associated With Poor Pharmacologic Adherence in Bipolar Disorder: Results From the STEP-BD Study

Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report

Genetic Association Study of Treatment Response With Olanzapine/Fluoxetine Combination or Lamotrigine in Bipolar I Depression

Efficacy of Agents in Treating Mania

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles